Objective Obesity is currently a major public health problem and one of the potential underlying causes of obesity in a minority of patients is Cushing's syndrome (CS) 
tients, who are increasingly present in the general population. (2) . Urinary free cortisol is also reported to be normal in obese individuals (3) . Biochemical confirmation of CS has relied upon low-dose dexamethasone suppression testing (4) . Low-dose dexamethasone suppression testing, especially the 1-mg overnight test, has been the mainstay of biochemical screening and is recommended in most standard texts (1) . Obese individuals seem to show adequate suppression after the overnight dexamethasone (1 mg) suppression test; although studies have shown that there is a small percent of no suppressors (5) . The methodology of cortisol assays has changed over time, with newer assays having higher specificity (1, 6) . To exclude CS, the concentration of cortisol in serum should be less than 50 nM after either test (7, 8) . While obesity is a common finding, CS resulting from either a pituitary or adrenal lesion is a relatively rare entity (9) .
The diagnosis of CS remains a challenge in clinical practice (1). CS is often diagnosed at an early stage in the natural history of the disease when there may be much more subtle clinical features. Basal morning cortisol and ACTH levels are usually normal in obesity
In a study by Ness-Abramof et al (5) , an overnight dexamethasone suppression test was performed in 86 obese individuals. Seventy (12) .
It was also reported that triglyceride and cholesterol levels are higher in patients with higher post-dexamethasone cortisol levels than in patients with fully suppressed cortisol levels (13) . It is also reported that subjects with non-alcoholic hepatic steatosis had a significantly higher postdexamethasone cortisol concentrations than those without HS (14) .
We therefore decided to re-examine the validity of the overnight 1- (19, 20) . The majority of previous studies and guidelines have used the 1-mg dose (21, 22) . According to one previous report, there appears to be no better discrimination with 1.5 mg or 2 mg of dexamethasone than with 1 mg administration (6) . In detail, cortisol suppression by 1 mg dexamethasone yielded the highest diagnostic performance with the 5-μg/dL threshold at 97% specificity, whereas the lower 1.8-μg/dL cutoff resulted in less optimal 80% specificity (22) . Ideally, the minimum number of investigations should be employed that allow accurate diagnosis and further management, and if at all possible these should be noninvasive (8) . Some patients with Cushing's disease retain sensitivity to dexamethasone and show suppression of serum cortisol to less than 50 nmol/L on either test (1, 19 (27) and Grossman et al (28) 
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